Infection with HTLV-1 can stimulate an abnormal increase of CD4+ T-cells which may bias ART strategies as CD4+ is a major immunological marker in HIV/AIDS monitoring and lead to a delay in ART initiation in regions where the WHO “test and treat” approach for HIV-1 infection is still to be implemented [15, 20]. The gene discussed is CD4; the disease is AIDS.